LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • November 8th, 2023 • Iris Parent Holding Corp. • Biological products, (no disgnostic substances) • Pennsylvania
THIS LICENSE AND DEVELOPMENT AGREEMENT (“Agreement”) is entered into as of June 10, 2018 (the “Effective Date”) between Liminatus Pharma, LLC, a Delaware limited liability company (“LIMINATUS”), and Targeted Diagnostics & Therapeutics, Inc. (“TDT”). LIMINATUS and TDT may each individually be referred to herein as a “Party” and may together be referred to herein as the “Parties.”
